The Journal of Medical Microbiology, Vol 48, Issue 12 1087-1093, Copyright © 1999 by Society for General Microbiology

JOURNAL ARTICLE

In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus

E. Dannaoui, E. Borel, F. Persat, M. F. Monier and M. A. Piens
Laboratoire de Parasitologie, Mycologie Medicale et Pathologie Exotique, Universite Claude Bernard Lyon I, France. edanna@rockefeller.univ-lyon1.fr

An animal model of disseminated aspergillosis was used to test the in-vivo activity of itraconazole against four isolates of Aspergillus fumigatus. Two reference isolates of A. fumigatus known to be resistant to itraconazole in vitro and in vivo were used as control isolates, and two new isolates were tested under the same conditions. For each isolate MICs for itraconazole and amphotericin B were determined by an NCCLS-based method. Mice infected intravenously were treated either with itraconazole 100 mg/ kg/day or amphotericin B 4.5 mg/kg/day for 10 days. Amphotericin B showed good in-vivo activity against all four isolates. For one strain, which had a low in-vitro MIC for itraconazole, in-vivo therapy with itraconazole prolonged the survival of mice and reduced fungal burdens in organs compared with untreated controls. In mice infected with a strain with a high MIC of >16 mg/L, itraconazole neither prolonged survival nor reduced fungal load in organs compared with controls. It is concluded that there is a relationship between MIC and treatment outcome in mice for A. fumigatus infection.

This article has been cited by other articles:

				M. A. Pfaller, S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, and D. J. Diekema In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species J. Clin. Microbiol., August 1, 2008; 46(8): 2568 - 2572. [Abstract] [Full Text] [PDF]

				L. E. Cowen and W. J. Steinbach Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance Eukaryot. Cell, May 1, 2008; 7(5): 747 - 764. [Full Text] [PDF]

				A. Alastruey-Izquierdo, M. Cuenca-Estrella, A. Monzon, E. Mellado, and J. L. Rodriguez-Tudela Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods J. Antimicrob. Chemother., April 1, 2008; 61(4): 805 - 809. [Abstract] [Full Text] [PDF]

				R. Dabur, T. K. Mandal, and G. L. Sharma Post-antifungal effects of the antifungal compound 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate on Aspergillus fumigatus J. Med. Microbiol., June 1, 2007; 56(6): 815 - 818. [Abstract] [Full Text] [PDF]

				L. Alcazar-Fuoli, E. Mellado, G. Garcia-Effron, M. J. Buitrago, J. F. Lopez, J. O. Grimalt, J. M. Cuenca-Estrella, and J. L. Rodriguez-Tudela Aspergillus fumigatus C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility Antimicrob. Agents Chemother., February 1, 2006; 50(2): 453 - 460. [Abstract] [Full Text] [PDF]

				G. Garcia-Effron, E. Mellado, A. Gomez-Lopez, L. Alcazar-Fuoli, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela Differences in Interactions between Azole Drugs Related to Modifications in the 14-{alpha} Sterol Demethylase Gene (cyp51A) of Aspergillus fumigatus Antimicrob. Agents Chemother., May 1, 2005; 49(5): 2119 - 2121. [Abstract] [Full Text] [PDF]

				M. Cuenca-Estrella, A. Gomez-Lopez, G. Garcia-Effron, L. Alcazar-Fuoli, E. Mellado, M. J. Buitrago, and J. L. Rodriguez-Tudela Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1232 - 1235. [Abstract] [Full Text] [PDF]

				J. Chen, H. Li, R. Li, D. Bu, and Z. Wan Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma J. Antimicrob. Chemother., January 1, 2005; 55(1): 31 - 37. [Abstract] [Full Text] [PDF]

				J. K. Imai, G. Singh, K. V. Clemons, and D. A. Stevens Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis Antimicrob. Agents Chemother., October 1, 2004; 48(10): 4063 - 4066. [Abstract] [Full Text] [PDF]

				E. Mellado, G. Garcia-Effron, L. Alcazar-Fuoli, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela Substitutions at Methionine 220 in the 14{alpha}-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2747 - 2750. [Abstract] [Full Text] [PDF]

				D. T. A. Te Dorsthorst, P. E. Verweij, J. F. G. M. Meis, N. C. Punt, and J. W. Mouton In Vitro Interactions between Amphotericin B, Itraconazole, and Flucytosine against 21 Clinical Aspergillus Isolates Determined by Two Drug Interaction Models Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2007 - 2013. [Abstract] [Full Text] [PDF]

				E. Dannaoui, J. Meletiadis, A.-M. Tortorano, F. Symoens, N. Nolard, M.-A. Viviani, M.-A. Piens, B. Lebeau, P. E. Verweij, and R. Grillot Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients J. Med. Microbiol., February 1, 2004; 53(2): 129 - 134. [Abstract] [Full Text] [PDF]

				T. M. Diaz-Guerra, E. Mellado, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela A Point Mutation in the 14{alpha}-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1120 - 1124. [Abstract] [Full Text] [PDF]

				J. Mosquera, A. Sharp, C. B. Moore, P. A. Warn, and D. W. Denning In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp. J. Antimicrob. Chemother., August 1, 2002; 50(2): 189 - 194. [Abstract] [Full Text] [PDF]

				E. Dannaoui, J. W. Mouton, J. F. G. M. Meis, and P. E. Verweij Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1953 - 1959. [Abstract] [Full Text] [PDF]

				J. Mosquera and D. W. Denning Azole Cross-Resistance in Aspergillus fumigatus Antimicrob. Agents Chemother., February 1, 2002; 46(2): 556 - 557. [Abstract] [Full Text] [PDF]

				J. H. Rex, M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, et al. Antifungal Susceptibility Testing: Practical Aspects and Current Challenges Clin. Microbiol. Rev., October 1, 2001; 14(4): 643 - 658. [Abstract] [Full Text] [PDF]

				E. Dannaoui, E. Borel, M.-F. Monier, M.-A. Piens, S. Picot, and F. Persat Acquired itraconazole resistance in Aspergillus fumigatus J. Antimicrob. Chemother., March 1, 2001; 47(3): 333 - 340. [Abstract] [Full Text] [PDF]

				E. DANNAOUI, E. BOREL, F. PERSAT, M.A. PIENS, and S. PICOT Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis J. Med. Microbiol., July 1, 2000; 49(7): 601 - 606. [Abstract] [Full Text] [PDF]